Trials / Conditions / Lung Adenocarcinoma, Stage I

Lung Adenocarcinoma, Stage I

6 registered clinical trials studyying Lung Adenocarcinoma, Stage I — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	SBU-RESET: RElaxation, Stress Reduction and Epigenetics Trial in Cancer Survivors NCT07161713	Barbara Nemesure	N/A
Withdrawn	SCION: SABR and Checkpoint Inhibition of NSCLC NCT04944173	University of British Columbia	Phase 2
Recruiting	Improving the Intraoperative Diagnosis Accuracy of Invasiveness for Small-sized Lung Adenocarcinoma NCT05830812	Union Hospital, Tongji Medical College, Huazhong University of Science and Technology	—
Unknown	Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adenocarcinoma NCT03254004	Samsung Medical Center	Phase 2
Recruiting	Surgery With or Without Chemotherapy for Stage I NSCLC With Micropapillary Component ≥ 20% NCT03351842	Shanghai Pulmonary Hospital, Shanghai, China	Phase 2
Unknown	Application of Detecting Circulating Tumor Cells in the Accurate Treatment of Early Stage Lung Adenocarcinoma NCT02951897	Third Military Medical University	N/A